[ad_1]
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
[ad_2]
[ad_1]
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
[ad_2]